Valneva SE

AYJ

Company Profile

  • Business description

    Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

  • Contact

    6 Rue Alain Bombard
    Saint-Herblain44800
    FRA

    T: +33 228073710

    E: [email protected]

    https://www.valneva.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    713

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,768.505.10-0.06%
CAC 407,557.310.85-0.01%
DAX 4023,649.30150.970.64%
Dow JONES (US)43,386.84404.410.94%
FTSE 1008,735.6016.850.19%
HKSE24,309.6815.72-0.06%
NASDAQ20,167.91194.360.97%
Nikkei 22540,155.78571.201.44%
NZX 50 Index12,530.3250.270.40%
S&P 5006,141.0248.860.80%
S&P/ASX 2008,541.109.70-0.11%
SSE Composite Index3,441.307.15-0.21%

Market Movers